Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small- cell lung cancer
Keywords:
Biomarkers, tumor
Immunotherapy
Lung neoplasms
Programmed cell death 1 receptor
Tumor microenvironment
Note:
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license
Citation:
Moutafi, M.K. (Myrto K.); Molero, M. (Magdalena); Martínez-Morilla, S. (Sandra); et al. "Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small- cell lung cancer". Journal for immunotherapy of cancer. 10 (8), 2022, e004757
Statistics and impact
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.